BioTai: BAT2206 obtains Singapore HSA listing approval

Baiao Tai announced that it has recently received the approval notice for the listing of BAT2206 from the Singapore Health Sciences Authority. BAT2206 has been approved for listing by NMPA, FDA, EMA, HSA, and the UK Medicines and Healthcare products Regulatory Agency, with commercial authorization cooperation covering 71 countries and regions worldwide.